West Pharmaceutical Services | WST - Cash And Equivalent

Stock Price
230.86
Daily Change
-6.19 -2.61%
Monthly
-17.79%
Yearly
-30.14%
Q1 Forecast
224.00

West Pharmaceutical Services reported $628.5M in Cash and Equivalent for its fiscal quarter ending in September of 2025.





Cash And Equivalent Change Date
Align Technology USD 1B 103.43M Sep/2025
Avanos Medical USD 70.5M 19.8M Sep/2025
Baxter International USD 1.73B 40M Sep/2025
Becton, Dickinson and Co. USD 641M 94M Sep/2025
Charles River Laboratories USD 207.1M 24.27M Sep/2025
Cooper Companies USD 124.9M 13.3M Jun/2025
Dentsply International USD 363M 4M Sep/2025
Haemonetics USD 363.37M 66.94M Dec/2025
ICU Medical USD 300.02M 10.32M Jun/2025
Insulet USD 757.4M 364.2M Sep/2025
Integra LifeSciences USD 232.19M 14.27M Sep/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
J&J USD 18.23B 10.35B Sep/2025
Medtronic USD 1.28B 9M Sep/2025
Merit Medical Systems USD 392.46M 50.64M Sep/2025
Neogen USD 145.34M 6.46M Sep/2025
Quidel USD 98.1M 53.6M Sep/2025
Repligen USD 748.75M 39.89M Sep/2025
Solventum Corp USD 1.64B 1.15B Sep/2025
STAAR Surgical USD 176.16M 9.02M Sep/2025
Terumo JPY 204.29B 17.58B Jun/2025
West Pharmaceutical Services USD 628.5M 118.8M Sep/2025